Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Treatment with pharmacological agents in peripheral arterial disease patients does not result in biomechanical gait changes.

Huisinga JM, Pipinos II, Stergiou N, Johanning JM.

J Appl Biomech. 2010 Aug;26(3):341-8.

PMID:
20841626
2.

Comparative effects of cilostazol and other therapies for intermittent claudication.

Dawson DL.

Am J Cardiol. 2001 Jun 28;87(12A):19D-27D. Review.

PMID:
11434896
3.

Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.

Stevens JW, Simpson E, Harnan S, Squires H, Meng Y, Thomas S, Michaels J, Stansby G.

Br J Surg. 2012 Dec;99(12):1630-8. doi: 10.1002/bjs.8895. Epub 2012 Oct 3. Review.

PMID:
23034699
5.

Pharmacotherapy for peripheral arterial disease: emerging therapeutic options.

Jaff MR.

Angiology. 2002 Nov-Dec;53(6):627-33. Review.

PMID:
12463615
6.

Treatment of intermittent claudication with pentoxifylline and cilostazol.

Tjon JA, Riemann LE.

Am J Health Syst Pharm. 2001 Mar 15;58(6):485-93; quiz 494-6. Review.

PMID:
11286146
7.
8.

Cilostazol: treatment of intermittent claudication.

Reilly MP, Mohler ER 3rd.

Ann Pharmacother. 2001 Jan;35(1):48-56. Review.

PMID:
11197586
9.

Treatment of intermittent claudication: cilostazol.

Collins P, Brittenden J.

Hosp Med. 2004 Aug;65(8):466-70. Review.

PMID:
15330347
10.

Medical management of peripheral arterial disease.

Creager MA.

Cardiol Rev. 2001 Jul-Aug;9(4):238-45. Review.

PMID:
11405904
11.

Drug treatment of intermittent claudication.

Jacoby D, Mohler ER 3rd.

Drugs. 2004;64(15):1657-70. Review.

PMID:
15257627
12.

Safety and efficacy of cilostazol in the management of intermittent claudication.

Chi YW, Lavie CJ, Milani RV, White CJ.

Vasc Health Risk Manag. 2008;4(6):1197-203. Review.

13.

Established and evolving medical therapies for claudication in patients with peripheral arterial disease.

Regensteiner JG, Stewart KJ.

Nat Clin Pract Cardiovasc Med. 2006 Nov;3(11):604-10. Review.

PMID:
17063165
14.

The US experience with cilostazol in treating intermittent claudication.

Hiatt WR.

Atheroscler Suppl. 2005 Dec 15;6(4):21-31. Epub 2005 Nov 4. Review.

PMID:
16275166
15.

Cilostazol: a new drug in the treatment intermittent claudication.

Kumar M, Bhattacharya V.

Recent Pat Cardiovasc Drug Discov. 2007 Nov;2(3):181-5. Review.

PMID:
18221117
16.

Cilostazol and peripheral arterial disease.

Pearce L, Ghosh J, Counsell A, Serracino-Inglott F.

Expert Opin Pharmacother. 2008 Oct;9(15):2683-90. doi: 10.1517/14656566.9.15.2683 . Review.

PMID:
18803454
17.

Cilostazol: a review of its use in intermittent claudication.

Chapman TM, Goa KL.

Am J Cardiovasc Drugs. 2003;3(2):117-38. Review.

PMID:
14727939
18.

Can claudication be improved with medication?

Conners MS, Money SR.

Semin Vasc Surg. 2002 Dec;15(4):237-44. Review.

PMID:
12478498
19.

Intermittent claudication: effective medical management of a common circulatory problem.

Beebe HG.

Am J Cardiol. 2001 Jun 28;87(12A):14D-18D. Review.

PMID:
11434895
20.

The role of cilostazol in the treatment of intermittent claudication.

Barnett AH, Bradbury AW, Brittenden J, Crichton B, Donnelly R, Homer-Vanniasinkam S, Mikhailidis DP, Stansby G.

Curr Med Res Opin. 2004 Oct;20(10):1661-70. Review.

PMID:
15462700
Items per page

Supplemental Content

Write to the Help Desk